Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Cell Markers of Marginal Zone Lymphoma and Other B-cell Chronic Lymphoid Malignancies

NCT04952974 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT04952974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04952974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Cell Markers of Marginal Zone Lymphoma and Other B-cell Chronic Lymphoid Malignancies
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Unknown status
Start date
June 14, 2021
Completion date
March 30, 2023
Enrollment
420 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, follicular lymphoma, hairy cell leukemia, lymphoplasmacytic lymphoma/waldenström macroglobulinemia, mantle cell lymphoma, marginal zone lymphoma